Cite
HARVARD Citation
Betu Kumeso, V. et al. (2023). Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. Lancet infectious diseases. 23 (4), pp. 463-470. [Online].